LAMISIL ATANTIFUNGAL (Novartis Consumer Health, Inc.)


Welcome to the PulseAid listing for the LAMISIL AT drug offered from Novartis Consumer Health, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Consumer Health, Inc.
NON-PROPRIETARY NAME: TERBINAFINE
SUBSTANCE NAME: TERBINAFINE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-01-01
END MARKETING DATE: 0000-00-00


LAMISIL AT ANTIFUNGAL HUMAN OTC DRUG Details:

Item DescriptionLAMISIL AT ANTIFUNGAL from Novartis Consumer Health, Inc.
LABELER NAME: Novartis Consumer Health, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/g)
START MARKETING DATE: 2010-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0067-6239_02859315-2972-4db0-b18a-b787385a6072
PRODUCT NDC: 0067-6239
APPLICATION NUMBER: NDA021958

Other TERBINAFINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Novartis Consumer Health, Inc.LAMISIL AT